Bluejay Diagnostics announces 1-for-8 reverse stock split

Bluejay Diagnostics Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-8. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on June 20, 2024, and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis on June 20, 2024 under the Company’s existing trading symbol, “BJDX.” At such time, the Company’s common stock will also commence trading with a new CUSIP number, 095633400.